Curatis Holding AG | WebDisclosure

Basculer en Français

11119	Companies
244817	Keywords
172888	Articles
131997	Press releases

Home
Companies
Curatis Holding AG

PRESS RELEASE

published on 09/16/2024 at 07:00, 2 years ago

Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs
Curatis Holding AG reports significantly increased revenue in core business and projects in development pipeline on track. Strong financial position and growth prospects highlighted in H1 2024 results

Financial Results Pharmaceutical Industry Revenue Business Development Curatis Holding AG
BRIEF

published on 09/12/2024 at 19:51, 2 years ago

Curatis Holding AG présentera ses résultats du premier semestre à Investora

Rapport Semestriel Soumission À La FDA Médicaments Orphelins Curatis Holding Conférence Investora
BRIEF

published on 09/12/2024 at 19:51, 2 years ago

Curatis Holding AG to Present at Investora and Release H1 Report Early

Half-year Report Orphan Drugs FDA Submission Curatis Holding Investora Conference
PRESS RELEASE

published on 09/12/2024 at 19:46, 2 years ago

Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September
Curatis Holding to participate in Investora on September 19, 2024, and release half-year report on September 16. Key executives to present the company at the conference

Conference Orphan Drugs Pharma Curatis Holding Investora
BRIEF

published on 08/27/2024 at 17:50, 2 years 1 month ago

Curatis sur la bonne voie : soumet une demande d'autorisation de mise sur le marché de médicaments orphelins pour un produit candidat clé aux États-Unis

Curatis Médicament Orphelin La FDA Tumeur Cérébrale Pédiatrique
BRIEF

published on 08/27/2024 at 17:50, 2 years 1 month ago

Curatis on Track: Submits Orphan Drug Application for Key Product Candidate in the US

FDA Curatis Orphan Drug Brain Tumor Pediatric
PRESS RELEASE

published on 08/27/2024 at 17:45, 2 years 1 month ago

Curatis auf Kurs: Einreichung des Antrags für Orphan-Drug-Designation des wichtigsten Produktkandidaten in den USA
Curatis Holding AG submits application for Orphan Drug Designation of lead product candidate C-PBTE-01 in the USA, targeting rare brain tumors affecting children

Orphan Drug Designation Rare Disease Curatis Holding AG C-PBTE-01 Childhood Cancer
BRIEF

published on 07/25/2024 at 07:05, 2 years 2 months ago

Curatis Holding AG : Initiation de la couverture par valuationLAB

Curatis Recherche Sur Les Actions C-PTBE-01 ÉvaluationLAB Médicaments Orphelins
BRIEF

published on 07/25/2024 at 07:05, 2 years 2 months ago

Curatis Holding AG: Initiation of Coverage by valuationLAB

Curatis Equity Research Orphan Drugs ValuationLAB C-PTBE-01
PRESS RELEASE

published on 07/25/2024 at 07:00, 2 years 2 months ago

Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB
Curatis Holding AG has initiated coverage and published an equity research report by valuationLAB estimating a risk-adjusted net present value of CHF 20.00 per share, signaling an enterprise value of CHF 103 million

Initiation Of Coverage Curatis Holding AG ValuationLAB Equity Research Report CHF 20.00 Per Share

Accesswire

Published on 10/03/2026 at 02:35, 1 day 13 hours ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 22 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 2 days 2 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 3 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 3 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/04/2026 at 06:05, 9 hours 55 minutes ago

Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 10 hours 45 minutes ago

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 16 hours ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 19 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding

Les Echos

Published on 10/02/2026 at 17:45, 1 day 22 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 22 hours ago

Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 22 hours ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 22 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 1 day 22 hours ago

Aéroports de Paris SA - Calendrier financier 2027

View all LES ECHOS COMFI WIRE